Acceptance and Commitment Therapy (ACT) Self-help to Reduce Stress
NCT ID: NCT03826732
Last Updated: 2020-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
133 participants
INTERVENTIONAL
2019-01-25
2020-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-help Books for Student Mental Health
NCT03779412
Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help (Phase II)
NCT02761681
A Prospective and Experimental Study on Efficacy of One-Day of Acceptance and Commitment Therapy on Mental Health Among University Students. a Psychological Capital Examine As Mediator to the Efficacy of ACT on Mental Health.
NCT06832462
Self-help Books for Social Anxiety
NCT03297619
Acceptance and Commitment Therapy (ACT) and Carers
NCT02584101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 140 participants will be recruited and randomised, using services on www.random.org. Informed consent will be obtained from all the participants ahead of screening. Participants will be asked to respond to the following questionnaires at pre-, post and follow-up assessments: Perceived Stress Scale-14 (PSS-14), General Anxiety Disorder-7 (GAD-7), Shirom Melamed Burnout Measure (SMBM), and Brunnsviken Brief Quality of Life Inventory (BBQ). Initially, they will also be asked to respond to the credibility/Expectancy Questionnaire (CEQ).
At the end of the intervention (week 10), participants will also be asked to respond to the Client Satisfaction Questionnaire (CSQ), and the Negative Effects Questionnaire (NEQ).
The following two scales will be used to study mediators: Acceptance and Action Questionnaire-2 (AAQ-2), and Attention Awareness Scale (MAAS), assess at pre-treatment, as well as at third and fifth week of treatment, at post-assessment (10 weeks later), and at the 6 months follow-up. A number of moderators, including demographics, will also be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Guided self-help based on ACT
Participants follow a self-help program and receive weekly support by trained facilitators
Guided self-help based on ACT
ACT-based self-help book and regular support by trained facilitators
Wait-list control
Participants are informed that they will receive the intervention after the 6-month follow-up assessment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guided self-help based on ACT
ACT-based self-help book and regular support by trained facilitators
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DASS score above 14
* PHQ-9 below 9
Exclusion Criteria
* Any indication of other psychiatric disorder in need of immediate attention/treatment
* Concurrent psychotherapy or other treatments for stress
* Previous work with the self-help book
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ata Ghaderi
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ata Ghaderi, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Solna, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGFLDE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.